載入...
Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance
While addition of the first-approved protease inhibitors (PIs), telaprevir and boceprevir, to pegylated interferon (PEG-IFN) and ribavirin (RBV) combination therapy significantly increased sustained virologic response (SVR) rates, PI-based triple therapy for the treatment of chronic hepatitis C viru...
Na minha lista:
| 發表在: | Viruses |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4926196/ https://ncbi.nlm.nih.gov/pubmed/27338446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v8060176 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|